INFU - InfuSystem Holdings Stock Price, News & Analysis

$2.24 0.09 (4.19 %)
(As of 11/24/2017 09:59 AM ET)
Previous Close$2.15
Today's Range$2.15 - $2.25
52-Week Range$1.20 - $2.60
Volume34,100 shs
Average Volume32,494 shs
Market Capitalization$51.26 million
P/E RatioN/A
Dividend YieldN/A

About InfuSystem Holdings (NYSEAMERICAN:INFU)

InfuSystem Holdings logoInfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
  • Previous Symbol: NYSE:INFU


    Debt-to-Equity RatioN/A
    Current RatioN/A
    Quick RatioN/A


    Trailing P/E RatioN/A
    Forward P/E RatioN/A
    P/E GrowthN/A

    Sales & Book Value

    Annual SalesN/A
    Price / SalesN/A
    Cash FlowN/A
    Price / CashN/A
    Book ValueN/A
    Price / BookN/A


    Annual DividendN/A
    Dividend YieldN/A


    Trailing EPS($0.14)
    Net IncomeN/A
    Net Margins-6.53%
    Return on Equity-9.02%
    Return on Assets-4.91%


    Outstanding Shares22,780,000

    Frequently Asked Questions for InfuSystem Holdings (NYSEAMERICAN:INFU)

    What is InfuSystem Holdings' stock symbol?

    InfuSystem Holdings trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."

    How were InfuSystem Holdings' earnings last quarter?

    InfuSystem Holdings Inc (NYSEAMERICAN:INFU) announced its quarterly earnings results on Monday, December, 12th. The medical instruments supplier reported $0.00 earnings per share (EPS) for the quarter. The medical instruments supplier earned $17.23 million during the quarter. InfuSystem Holdings had a negative net margin of 6.53% and a negative return on equity of 9.02%. View InfuSystem Holdings' Earnings History.

    Who are some of InfuSystem Holdings' key competitors?

    Who are InfuSystem Holdings' key executives?

    InfuSystem Holdings' management team includes the folowing people:

    • Gregg O. Lehman Ph.D., Executive Chairman of the Board (Age 67)
    • Richard A. Diiorio, President, Chief Executive Officer, Director (Age 43)
    • Christopher Downs, Interim Chief Financial Officer, Executive Vice President (Age 59)
    • Janet Skonieczny, Chief Operating Officer, Executive Vice President, Compliance Officer and Privacy Officer (Age 56)
    • Trent N Smith, Executive Vice President, Chief Accounting Officer, Corporate Controller (Age 48)
    • Michael Milton McReynolds, Executive Vice President, Chief Information Officer (Age 46)
    • Darrell B. Montgomery, Director (Age 55)
    • Ryan J. Morris, Director (Age 32)
    • Christopher R. Sansone, Director
    • Scott A. Shuda, Director (Age 50)

    How do I buy InfuSystem Holdings stock?

    Shares of InfuSystem Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

    What is InfuSystem Holdings' stock price today?

    One share of InfuSystem Holdings stock can currently be purchased for approximately $2.24.

    How big of a company is InfuSystem Holdings?

    InfuSystem Holdings has a market capitalization of $51.26 million.

    How can I contact InfuSystem Holdings?

    InfuSystem Holdings' mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.

    MarketBeat Community Rating for InfuSystem Holdings (INFU)

    Community Ranking:  2.7 out of 5 (star star)
    Outperform Votes:  34 (Vote Outperform)
    Underperform Votes:  28 (Vote Underperform)
    Total Votes:  62
    MarketBeat's community ratings are surveys of what our community members think about InfuSystem Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

    Analyst Ratings

    Analysts' Consensus Rating for InfuSystem Holdings (NYSEAMERICAN:INFU)

      (How are Consensus Ratings Calculated?)
    Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
    Consensus Rating:N/A (Score: NaN)
    Analysts' Consensus Price Target: N/A

    Consensus Price Target History for InfuSystem Holdings (NYSEAMERICAN:INFU)

    Price Target History for InfuSystem Holdings (NYSEAMERICAN:INFU)

    Analysts' Ratings History for InfuSystem Holdings (NYSEAMERICAN:INFU)

    No equities research coverage for this company has been tracked by


    Earnings History and Estimates Chart for InfuSystem Holdings (NYSEAMERICAN:INFU)

    Earnings by Quarter for InfuSystem Holdings (NYSEAMERICAN:INFU)

    Earnings History by Quarter for InfuSystem Holdings (NYSEAMERICAN INFU)

    DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
    8/9/2017Q2 2017($0.02)$16.94 millionViewListenView Earnings Details
    3/22/2017Q4 2016$0.07($0.01)$16.85 millionViewN/AView Earnings Details
    12/12/2016Q3 2016$0.00$17.23 millionViewN/AView Earnings Details
    8/10/2016Q216$0.04$17.20 million$19.10 millionViewListenView Earnings Details
    5/10/2016Q116$0.02$16.70 million$19.00 millionViewN/AView Earnings Details
    11/12/2015Q315$0.06$18.69 millionViewListenView Earnings Details
    5/12/2015Q115$0.06$0.03$17.20 million$16.70 millionViewListenView Earnings Details
    3/9/2015Q414$0.05$0.05$17.20 million$16.20 millionViewN/AView Earnings Details
    11/10/2014Q3 2014$0.05$0.04$16.61 millionViewN/AView Earnings Details
    8/1/2014Q2 2014$0.04$16.37 millionViewN/AView Earnings Details
    5/5/2014Q1 2014$0.03$0.03$17.24 millionViewN/AView Earnings Details
    3/11/2014$0.03$0.04ViewN/AView Earnings Details
    11/12/2013Q3$0.02$0.03ViewListenView Earnings Details
    (Data available from 1/1/2011 forward)


    Earnings Estimates for InfuSystem Holdings (NYSEAMERICAN:INFU)

    No earnings estimates for this company have been tracked by


    Dividend History for InfuSystem Holdings (NYSEAMERICAN:INFU)
    No dividend announcements for this company have been tracked by

    Insider Trades

    Insider Trading and Institutional Ownership History for InfuSystem Holdings (NYSEAMERICAN INFU)

    Insider Trades by Quarter for InfuSystem Holdings (NYSEAMERICAN:INFU)
    Institutional Ownership by Quarter for InfuSystem Holdings (NYSEAMERICAN:INFU)

    Insider Trades by Quarter for InfuSystem Holdings (NYSEAMERICAN INFU)

    Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
    11/21/2017Christopher R SansoneDirectorBuy54,344$2.09$113,578.96View SEC Filing  
    9/11/2017Meridian Ohc Partners, LpDirectorBuy19,982$2.00$39,964.00View SEC Filing  
    8/30/2017Meridian Ohc Partners, LpDirectorBuy30,900$1.90$58,710.00View SEC Filing  
    8/28/2017Meridian Ohc Partners, LpDirectorBuy30,000$1.90$57,000.00View SEC Filing  
    8/25/2017Meridian Ohc Partners, LpDirectorBuy13,381$1.84$24,621.04View SEC Filing  
    8/24/2017Meridian Ohc Partners, LpDirectorBuy155$1.80$279.00View SEC Filing  
    8/23/2017Meridian Ohc Partners, LpDirectorBuy2,166$1.80$3,898.80View SEC Filing  
    8/16/2017Meridian Ohc Partners, LpDirectorBuy56,670$1.84$104,272.80View SEC Filing  
    8/15/2017Richard DilorioDirectorBuy4,875$1.95$9,506.25View SEC Filing  
    8/14/2017Christopher DownsCFOBuy7,900$1.90$15,010.00View SEC Filing  
    8/14/2017Darrell B MontgomeryDirectorBuy25,000$1.88$47,000.00View SEC Filing  
    6/7/2017Meridian Ohc Partners, LpDirectorBuy10,109$1.55$15,668.95View SEC Filing  
    6/2/2017Meridian Ohc Partners, LpDirectorBuy10,100$1.55$15,655.00View SEC Filing  
    5/25/2017Meridian Ohc Partners, LpDirectorBuy6,105$1.55$9,462.75View SEC Filing  
    5/19/2017Ryan J MorrisDirectorBuy15,000$1.28$19,200.00View SEC Filing  
    5/17/2017Ryan J MorrisDirectorBuy29,614$1.45$42,940.30View SEC Filing  
    3/27/2017Ryan J MorrisDirectorBuy21,651$2.20$47,632.20View SEC Filing  
    3/24/2017Ryan J MorrisDirectorBuy94,200$2.14$201,588.00View SEC Filing  
    12/19/2016Eric K. SteenInsiderBuy12,000$2.33$27,960.00View SEC Filing  
    12/16/2016Meridian Ohc Partners, LpDirectorBuy200,000$2.34$468,000.00View SEC Filing  
    9/14/2016Ryan J MorrisDirectorBuy23,171$2.85$66,037.35View SEC Filing  
    9/13/2016Ryan J MorrisDirectorBuy16,829$2.88$48,467.52View SEC Filing  
    9/8/2016Ryan J MorrisDirectorBuy17,171$2.84$48,765.64View SEC Filing  
    9/2/2016Ryan J MorrisDirectorBuy4,600$2.84$13,064.00View SEC Filing  
    11/19/2015Eric K. SteenCEOBuy2,461$2.88$7,087.68View SEC Filing  
    11/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy29,600$2.82$83,472.00View SEC Filing  
    11/3/2015Meridian Ohc Partners, LpMajor ShareholderBuy7,689$2.75$21,144.75View SEC Filing  
    10/28/2015Meridian Ohc Partners, LpMajor ShareholderBuy17,100$2.71$46,341.00View SEC Filing  
    10/13/2015Meridian Ohc Partners, LpMajor ShareholderBuy14,290$2.82$40,297.80View SEC Filing  
    10/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy1,860$2.83$5,263.80View SEC Filing  
    8/24/2015Eric K. SteenCEOBuy5,000$2.83$14,150.00View SEC Filing  
    8/19/2015Eric K. SteenCEOBuy7,360$2.92$21,491.20View SEC Filing  
    8/18/2015Jonathan P FosterCFOBuy1,000$2.92$2,920.00View SEC Filing  
    6/23/2015Meridian Ohc Partners, LpMajor ShareholderBuy7,500$3.19$23,925.00View SEC Filing  
    6/15/2015Gregg Owen LehmanDirectorBuy2,000$3.23$6,460.00View SEC Filing  
    6/12/2015Meridian Ohc Partners, LpMajor ShareholderBuy12,786$3.16$40,403.76View SEC Filing  
    6/8/2015Gregg Owen LehmanDirectorBuy18,000$3.19$57,420.00View SEC Filing  
    6/4/2015David C DreyerDirectorSell10,000$3.15$31,500.00View SEC Filing  
    6/4/2015Meridian Ohc Partners, LpMajor ShareholderBuy19,550$3.15$61,582.50View SEC Filing  
    5/19/2015Eric K SteenCEOBuy5,682$3.08$17,500.56View SEC Filing  
    5/15/2015Jonathan P FosterCFOBuy4,270$3.07$13,108.90View SEC Filing  
    12/16/2014Eric K SteenCEOBuy15,100$2.73$41,223.00View SEC Filing  
    12/4/2014Eric K SteenCEOBuy3,669$2.65$9,722.85View SEC Filing  
    11/26/2014Eric K SteenCEOBuy10,000$2.75$27,500.00View SEC Filing  
    11/17/2014Eric K SteenCEOBuy10,000$2.69$26,900.00View SEC Filing  
    8/27/2014Eric K SteenCEOBuy15,000$2.75$41,250.00View SEC Filing  
    8/18/2014Eric K SteenCEOBuy12,750$2.79$35,572.50View SEC Filing  
    8/13/2014Eric K SteenCEOBuy7,262$2.79$20,260.98View SEC Filing  
    8/11/2014Eric K SteenCEOBuy11,172$2.71$30,276.12View SEC Filing  
    5/7/2014Eric K SteenCEOBuy10,000$2.80$28,000.00View SEC Filing  
    3/17/2014Ryan J MorrisChairmanSell24,600$2.90$71,340.00View SEC Filing  
    3/13/2014Jonathan P FosterCFOBuy5,000$2.78$13,900.00View SEC Filing  
    8/14/2013Eric K SteenCEOBuy15,000$1.42$21,300.00View SEC Filing  
    (Data available from 1/1/2013 forward)


    Latest Headlines for InfuSystem Holdings (NYSEAMERICAN INFU)


    Social Media

    Social activity is not available for this stock.



    InfuSystem Holdings (NYSEAMERICAN INFU) Chart for Friday, November, 24, 2017
    Loading chart…

    This page was last updated on 11/24/2017 by Staff

    Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.